The Center for Integrated BioSystems, USU

Biotech News

Provided courtesy of: http://news.search.yahoo.com/news

BSI Proteomics to Determine Structure of CF Membrane Protein (GenomeWeb News): Sat, 07 Nov 2009 13:16:12 GMT - NEW YORK, March 21 (GenomeWeb News) - BSI Proteomics said last week that it will perform protein crystallization and structure determination services for the Cystic Fibrosis Foundation.
Monsanto Opening Beijing Genomics, Biotech Center (GenomeWeb News): Wed, 04 Nov 2009 19:45:32 GMT - NEW YORK (GenomeWeb News) â€“ Monsanto said today that it will open a research center in Beijing that will focus on collaborations with Chinese research institutions in plant biotechnology and genomics research.
MSU, UK, MIT to Run Plant Genomics Studies for Rx Uses (GenomeWeb News): Fri, 06 Nov 2009 20:00:42 GMT - NEW YORK (GenomeWeb News) â€“ Scientists at three universities will use $6 million in funding from the National Institutes of Health to conduct genomics research on plants that may have properties that could be used in developing new drugs, according to Michigan State University.
U.S. biotech firm opens biotechnology research center in China (People's Daily): Thu, 05 Nov 2009 10:26:38 GMT - The U.S. Monsanto Company announced on Thursday that it has opened its first research center in China. The Monsanto Biotechnology Research Center in Zhongguancun, Beijing, is expected to strengthen the company' s ties with Chinese research institutions in plant biotechnology and genomics. Stephen Padgette, vice president of biotechnology for Monsanto, said that Monsanto has made a commitment to ...
Final Glance: Biotechnology companies (AP via Yahoo! Finance): Fri, 06 Nov 2009 22:55:32 GMT - NEW YORK (AP) -- Shares of some top biotechnology companies were up at the close of trading: Amgen rose $.64 or 1.2 percent, to $54.69. Biogen Idec rose $1.37 or 3.1 percent, to $45.76. Celgene rose $1.22 or 2.3 percent, to $53.05. Gilead Sciences rose $.76 or 1.7 percent, to $46.26.
Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes (EurekAlert!): Thu, 05 Nov 2009 19:27:58 GMT - ( Complete Genomics ) Complete Genomics, a third-generation human genome sequencing company, today announced publication of a report in the journal Science describing its proprietary DNA sequencing platform, including analysis of sequence data from three complete human genomes. The consumables cost for these three genomes sequenced on the proof-of-principle genomic DNA nanoarrays ranged from $8 ...
Midday Glance: Biotechnology companies (AP via Yahoo! Finance): Fri, 06 Nov 2009 17:18:31 GMT - NEW YORK (AP) -- Shares of some top biotechnology companies are up at noon: Amgen rose $.45 or .8 percent, to $54.50. Biogen Idec rose $.48 or 1.1 percent, to $44.87. Celgene rose $.93 or 1.8 percent, to $52.76. Gilead Sciences rose $.53 or 1.2 percent, to $46.03.
Complete Genomics reports low-cost sequencing of 3 human genomes (PhysOrg): Thu, 05 Nov 2009 20:05:50 GMT - Complete Genomics, a third-generation human genome sequencing company, today announced publication of a report in the journal Science describing its proprietary DNA sequencing platform, including analysis of sequence data from three complete human genomes. The consumables cost for these three genomes sequenced on the proof-of-principle genomic DNA nanoarrays ranged from $8,005 for 87x coverage ...
Early Glance: Biotechnology companies (AP via Yahoo! Finance): Fri, 06 Nov 2009 15:32:16 GMT - NEW YORK (AP) -- Shares of some top biotechnology companies are up at 10 a.m.: Amgen rose $.55 or 1.0 percent, to $54.60. Biogen Idec rose $.23 or .5 percent, to $44.62. Celgene rose $.80 or 1.5 percent, to $52.63. Gilead Sciences rose $.76 or 1.7 percent, to $46.26.
Complete Genomics Gets Gene Sequencing Under $5,000 (Update1) (Bloomberg): Thu, 05 Nov 2009 21:59:29 GMT - Nov. 5 (Bloomberg) -- Complete Genomics , a Silicon Valley company backed by venture capitalists, produced complete sequences of three peopleâ€™s DNA at an average cost of $4,500, accelerating the race to develop faster, cheaper gene-mapping systems.

Cloned horses latest move for controversial field: Friday Mar 31, 2006 - WASHINGTON (Reuters) - The company that cloned the first horse to be sold commercially said on Thursday it plans to market 22 similar animals before 2008, marking another step forward for the controversial technology.
Biologists Take Big Step to Keep Park's Little Cutthroats From Being Devoured: Tuesday Nov 8, 2005 - YELLOWSTONE NATIONAL PARK, Wyo. - An unusual fishing season just ended on Yellowstone Lake. The take included 36,000 lake trout caught, killed and sunk to the bottom of the lake. And the fishers are not finished.
A Special Drug Just for You, at the End of a Long Pipeline: Tuesday Nov 8, 2005 - A new drug for acne, Aczone, was approved in July, but with a catch. The Food and Drug Administration said it would require that patients first be tested for an enzyme deficiency that could put them at risk of developing anemia from the drug.
U.S. companies to launch corn-based socks in Japan: Tuesday Nov 8, 2005 - TOKYO (Reuters) - The Chicago White Sox may have won baseball's World Series, but the corn socks are coming to Japan. Biodegradable socks, made from corn-derived fiber and manufactured by U.S. hosiery makers, should make their worldwide debut on Japanese store shelves sometime next year, industry officials said on Tuesday.
New "chip" could provide quick bird flu test: Tuesday Nov 8, 2005 - WASHINGTON (Reuters) - A new "chip" can test for 11 different influenza strains, including avian flu, in less than a quarter of the time it now takes to diagnose flu in patients, U.S. researchers said on Monday.
Prince Charles urges environment moves: Tuesday Nov 8, 2005 - SAN FRANCISCO (Reuters) - Britain's Prince Charles and his wife, Camilla, toured a landmark San Francisco building renovated to showcase organic foods on Monday and followed the visit by telling California business leaders that urgent action is needed to address environmental challenges.
Past pandemics that ravaged Europe: Monday Nov 7, 2005 - In 430BC, during the Peloponnesian war against their great rival Sparta, the people of Athens were hit by a deadly disease that has defied diagnosis to this day.
U. makes a healing 'bio-paper': Saturday Nov 5, 2005 - (Deseret Morning News) An emerging branch of medicine called "organ printing" takes a patient's own healthy cells and uses a printer, cell-based "bio-ink" and "bio-paper" to create tissue to repair a damaged organ.
Americans split over buying cloned meat: poll: Friday, Nov 4, 2005 - WASHINGTON (Reuters) - Two-thirds of U.S. consumers said they would either buy or consider buying meat and milk made from cloned animals if the U.S. government declared cloning safe, according to the results of a public opinion poll released on Friday.
EU authorizes GMO maize type by legal rubberstamp: Monday, August 8, 2005 - The European Union authorized imports of a genetically modified (GMO) maize on Monday, the third GMO product to win approval since the EU ended its unofficial biotech ban last year, officials said.
Cloning Man’s Best Friend: Friday, August 6, 2005 - Hwang Woo-suk, the stem-cell pioneer who led the team that cloned the world’s first dog, explains why they did it and why they believe Snuppy could benefit all of mankind.
Ghana stops importation of GM Foods: Thursday, July 28, 2005 - Ghana has taken a strong stance against the importation and cultivation of Genetically Modified (GM) foods in Ghana.
GM potato uses frog gene to resist pathogens: Thursday, July 28, 2005 - A chemical that South American frogs excrete from their skin could protect potatoes and other crops from a range of diseases, according to biotechnologists in Canada.
Skin Cancer Breakthrough in an Egg: Sunday, July 24, 2005 - CHICKEN eggs containing a drug that can target and treat skin cancer have been produced by Scottish scientists.
Pakistan, India And US Biotechnology Ties: Monday, July 11, 2005 - All three countries Pakistan, India and USA are building closer science ties with each other in a range of fields spanning crops biotechnology to overcome its agriculture issues. Pakistan stands to gain tremendously from the tripartite planning meeting on agricultural biotechnology held at Lahore at the end of May 2005.
ARS to be part of new team improving Cassava: Friday, July 11, 2005 - Cassava, one of the most important food crops in Africa, is about to undergo an extreme makeover in a multimillion-dollar project that will include an Agricultural Research Service scientist as part of the interdisciplinary team.
Biotech acreage on the rise across U.S.: Saturday, July 09, 2005 - As part of the latest NASS acreage survey, farmers’ use of biotechnology-derived crops was detailed. The numbers aren’t growing by leaps and bounds lately, but they are growing.